Page last updated: 2024-10-15

mast cell degranulating peptide

Description

mast cell degranulating peptide: isolated from bee venoms; made up of 22 amino acids; has 2 disulfide bridges [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID16132290
MeSH IDM0052066

Synonyms (6)

Synonym
gtpl2548
mast cell degranulating peptide
mast cell degranulating peptide (honeybee reduced) cyclic (3-15),(5-19)-bis(disulfide)
mcd peptide
mast cell degranulating peptide (honeybee)
Q27083604

Dosage Studied

ExcerptReference
" Moreover, the peptide administration was able to produce in vivo degranulation of mouse mast cells, in a dose-response manner."( Echinometrin: a novel mast cell degranulating peptide from the coelomic liquid of Echinometra lucunter sea urchin.
de Melo, RL; Giorgi, R; Gonçalves, LR; Nogueira, Tde O; Pimenta, DC; Sampaio, MC; Sciani, JM; Teixeira, Cde F; Zychar, BC, 2014
)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID1346657Human Kv1.6 (Voltage-gated potassium channels)1990The EMBO journal, Jun, Volume: 9, Issue:6
Cloning and expression of a human voltage-gated potassium channel. A novel member of the RCK potassium channel family.
AID1346690Mouse Kv1.1 (Voltage-gated potassium channels)1994Molecular pharmacology, Jun, Volume: 45, Issue:6
Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
AID1346704Rat Kv1.2 (Voltage-gated potassium channels)1994Molecular pharmacology, Jun, Volume: 45, Issue:6
Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (101)

TimeframeStudies, This Drug (%)All Drugs %
pre-199039 (38.61)18.7374
1990's42 (41.58)18.2507
2000's16 (15.84)29.6817
2010's4 (3.96)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews7 (6.67%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other98 (93.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]